NEUROPEN

Gabapentin

Composition : Gabapentin USP 300mg Tablet.

Indication : Neuropen (gabapentin) is indicated for the management of postherpetic neuralgia in adults. Neuropen (gabapentin) is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy. Neuropen is also indicated as adjunctive therapy in the treatment of partial seizures in pediatric patients age 3-12 years.

Dosage and administration : Postherpetic Neuralgia : In adults with postherpetic neuralgia, Neuropen therapy may be initiated as a single 300mg dose on day 1, 600 mg /day on day 2 (divided BID), and 900 mg/day on day 3 (divided TID). The dose can subsequently be titrated up to as needed for pain relief to a daily dose of 1800 mg. Epilepsy : Patients >12 years of age : The effective dose of Neuropen is 900 to 1800 mg /day and given in divided doses (three times a day). The starting dose is 300 mg three times a day. In case of Children 3-12 years : The starting dose should range from 10-15 mg /kg/day in 3 divided doses. The effective dose of Neuropen in patients 5 years of age and older is 25-35 mg/kg/day and given in divided doses. Or, as directed by the registered physicians.

Use in pregnancy and lactation : Pregnancy Category C by FDA.

Packing : Neuropen : 3x10's tablets in blister pack.